Whitehawk Therapeutics, Inc. (WHWK)

CIK 0001422142 · Healthcare · Biotechnology

Recent Filing Index

Form Filed Qtr End F_Period 8K: Earnings Release
Latest Q2-2026 8-K (2026-08-06) · 99.1
Q1-2026 8-K (2026-05-07) · 99.1
Latest FY-2025 8-K (2026-03-12) · 99.1
Q3-2025 8-K (2025-11-06) · 99.1
Q2-2025 8-K (2025-08-07) · 99.1
Q1-2025 8-K (2025-05-08) · 99.1
FY-2024 8-K (2025-03-18) · 99.1
Q3-2024 8-K (2024-11-06) · 99.1
Q2-2024 8-K (2024-08-07) · 99.1
Q1-2024 8-K (2024-05-08) · 99.1
FY-2023 8-K (2024-03-13) · 99.1
Q3-2023 8-K (2023-11-08)

Filing Summary

Report Name | Notes Fiscal Period (Annual) Fiscal Period (Quarter)
Cover Page
Audit Information
—
Statements
Balance Sheets
—
Consolidated Balance Sheets
Balance Sheets (P)
Consolidated Balance Sheets (P)
Condensed Consolidated Statements of Operations and Comprehensive (loss) Income (unaudited)
—
Condensed Consolidated Statements of Operations and Comprehensive Income (loss)
—
Condensed Statements of Operations and Comprehensive (loss) Income
—
Statements of Operations and Comprehensive Loss
—
Consolidated Statements of Operations and Comprehensive Loss
Consolidated Statements of Stockholders' Equity
Statements of Stockholders' Equity
Consolidated Statements of Cash Flows
Statements of Cash Flows
Notes
Accrued Liabilities
Commitments and Contingencies
Cybersecurity Risk Management and Strategy Disclosure
—
Cybersecurity Risk Management, Strategy, and Governance
—
Divestiture of Fyarro
Employee Retirement Plan
—
Employee Stock Purchase Plan
Fair Value Measurement
Income Taxes
Insider Trading Arrangements
Insider Trading Policies and Procedures
—
Intangible Asset
License Agreements
Nature of Organization and Operations
Operating Leases
Pay Vs Performance Disclosure
Restructuring
Segment Information
Share-based Compensation
Short-term Investments and Cash Equivalents
Stockholders' Equity
Stockholders' Equity (deficit)
—
Subsequent Events
—
Summary of Significant Accounting Policies